Dr. Ying Mei's lab at Clemson University focuses on using advanced materials to develop innovative treatments for heart repair, specifically targeting cardiovascular diseases. The research primarily involves creating human heart organoids from stem cells, enhanced with silicon nanowires for better function and survival after implantation. By exploring hypoimmunogenic properties, the lab aims to produce organoids that can be used as off-the-shelf therapies for patients who have suffered heart injuries.

Dr. Naren Vyavahare's lab at Clemson University focuses on developing innovative therapies for aortic aneurysms, a serious cardiovascular condition. The research involves using nanoparticle systems to target and repair damaged vascular elastin, which is crucial for preventing aneurysm ruptures. By applying these therapies in preclinical models, the lab aims to create a non-invasive treatment that could change how these dangerous conditions are managed, potentially saving lives and improving patient outcomes.

Dr. Hai Yao's lab at Clemson University focuses on understanding the mechanics and biology of the temporomandibular joint (TMJ) in patients with craniofacial skeletal deformities, like Class II and Class III malocclusions. By studying how these jaw structures influence TMJ function before and after surgical interventions, they aim to improve treatment strategies and patient outcomes. Their research combines anatomical analysis with advanced biomechanics to identify risk factors for TMJ disorders and to evaluate the effectiveness of orthognathic surgery.